Altman Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.09M | Buy |
17,000
+547
| +3% | +$67.3K | 0.85% | 52 |
|
|
2025
Q1 | $1.87M | Buy |
16,453
+509
| +3% | +$57.8K | 0.86% | 53 |
|
|
2024
Q4 | $1.55M | Buy |
15,944
+288
| +2% | +$28K | 0.66% | 69 |
|
|
2024
Q3 | $1.8M | Buy |
15,656
+90
| +0.6% | +$10.4K | 0.8% | 58 |
|
|
2024
Q2 | $1.66M | Buy |
15,566
+50
| +0.3% | +$5.32K | 0.94% | 46 |
|
|
2024
Q1 | $1.49M | Buy |
15,516
+582
| +4% | +$55.8K | 0.72% | 67 |
|
|
2023
Q4 | $1.51M | Buy |
14,934
+217
| +1% | +$21.9K | 0.79% | 57 |
|
|
2023
Q3 | $1.5M | Buy |
+14,717
| New | +$1.5M | 0.94% | 33 |
|
|
2023
Q1 | $1.35M | Buy |
+14,709
| New | +$1.35M | 1.24% | 28 |
|